[17/01/2025, 17:01] Rakesh Biswas: Reviewed the patient today in ICU (forgot to post this earlier)
Has started having severe epigastric abdominal pain again since yesterday
Along with vomiting
On examination:
Abdomen soft
Working diagnosis:
Drug induced gastritis
Plan @PI Portal Hypertension Project 2022 @Pushed Comm 1AI23 @Communicating Learner 1N23
Hold the tablet prednisolone for a few days
Repeat LFT
Serum creatinine
Urine for 24 hour protein and creatinine
Temporarily withhold
[17/01/2025, 17:04] Rakesh Biswas: Everytime since last few years when she developed florid proteinuria she would clinically go into remission (although not documented in 24 hour values, the nearest was probably 700 mg recently during last admission when we were battling the ravages of her pyopneumothorax) following which after the steroids were tapered due to the infection, she again developed this florid proteinuria since two weeks which doesn't seem to be responding to the 30 mg of prednisolone this time, which is on the contrary producing side effects!
[20/01/2025, 09:09] Rakesh Biswas: Update?
Is she getting discharged?
Any repeat 24 hour protein creatinine results in this admission?
Is she on physiological doses of her previous 30 mg prednisolone that had to be withheld due to suspected gastritis?
[20/01/2025, 09:10] Rakesh Biswas: @Kundana 2019 who requested entry to this group can you please introduce yourself?
[20/01/2025, 09:21] Pushed Communicator 1N22: Yes sir
Planning for discharge today
Pedal edema and abd distension subsided sir
No pain abdomen nausea and vomitings
She is taking food as before
[20/01/2025, 09:22] Pushed Communicator 1N22: We stopped prednisolone and azathioprine for the last 3 days sir
Shall we put her back on those and discharge today sir ?
[20/01/2025, 09:27] Rakesh Biswas: Calculate the actual GFR using the urinary creatinine. @Durga Krishna 2020 Pg 29f Patient Adv 2 @Inner Strength Engineer1 can you help?
[20/01/2025, 16:18] Durga Krishna 2020 Pg 29f Patient Adv 2: What was her serum creatinine value ??
[20/01/2025, 16:21] PI Portal Hypertension Project 2022: Creatinine is 0.8mg/dl sir
[20/01/2025, 16:24] Rakesh Biswas: But remember for gfr calculation from urinary creatinine (this is not e gfr) you need to use the urinary creatinine, the 24 hour urinary volume and other parameters in the formula
[20/01/2025, 16:24] Durga Krishna 2020 Pg 29f Patient Adv 2: Ok sir.
[21/01/2025, 10:14] Rakesh Biswas: Yesterday's EMR discharge summary to be updated in the case report:
Age/Gender : 23 Years/Female
Address :
Discharge Type: Relieved
Admission Date: 17/01/2025 03:31 PM
Name of Treating Faculty
DR VAMSHI KRISHNA [ASST.PROFSSOR] DR PRACHETHAN PGY3
DR RAVI PGY2
Diagnosis
1. DRUG INDUCED GASTRITIS ? ORAL STEROIDS INDUCED
2. LUPUS NEPHRITIS WITH FLARE
3. INFLAMMMATORY COLITIS
4. K/C/O SYSTEMIC LUPUS ERYTHEMATOSIS [SLE] SINCE 4 YEARS
Case History and Clinical Findings
C/O PAIN ABDOMEN SINCE YESTERDAY NIGHT C/O VOMTINGS SINCE TODAY MORNING HISTORY OF PRESENTING ILLNESS:
PATIENT WAS APPARENTLY ASYMPTOMATIC 1DAYS AGO,THEN SHE DEVELOPED PAIN ABDOMEN SINCE YESTERDAY NIGHT AT EPIGASTRIC REGION TENDERNESS PRESENT ASSOCIATED WITH VOMITINGS SINCE TODAY MORNING THREE EPISODES, NON BILIOUS, NON PROJECTILE,NON BLOOD STAINED ,WATER AS CONTENT
NO AGGRAVATING AND RELIEVING FACTORS ASSOCIATED WITH NAUSEA
H/O PEDAL EDEMA AND FACIAL PUFFINESS SINCE 25 DAYS
NO H/O FEVER, COLD, COUGH, ALLERGIES, CHEST PAIN, PALPITATIONS, SWEATING, SOB, BURNING MICTURITION, CONSTIPATION
PAST HISTORY:
K/C/O SLE , LUPUS NEPHRITIS AND INFECTIVE COLITIS N/K/C/O DM II, TB, EPILEPSY, ASTHMA, CVA,CAD
FAMILY HISTORY:
INSIGNIFANCT PERSONAL HISTORY:
SLEEP- ADEQUATE APPETITE-NORMAL DIET-MIXED
BOWEL AND BLADDER MOVEMENTS-REGULAR ADDICTIONS-NIL
GENERAL PHYSICAL EXAMINATION:
TEMPERATURE-AFEBRILE BP-160/100MMHG
PR-156BPM RR-22CPM
SPO2-98%AT RA
MILD BILATERAL PEDAL EDEMA PRESENT [PITTING TYPE]
NO PALLOR, ICTERUS, CYANOSIS, CLUBBING, LYMPHADENOPATHY, MALNUTRITION CVS - S1, S2 HEARD, NO MURMURS.
RS- B/L AE - PRESENT, NVBS, NO ADDED SOUNDS.
P/A - SOFT, TENDERNESS AT EPIGASTRIC REGION, NO ORGANOMEGALY, BOWEL SOUNDS PRESENT
CNS-NO FOCAL NEUROLOGICAL DEFICIT LOCAL EXAMINATION:
PER ABDOMENSOFT, TENDERNESS AT EPIGASTRIC REGION, BOWEL SOUNDS PRESENT, NO ORGANOMEGALY
NO GUARDING, NO RIGIDITY NO SCARS
Investigation
Anti HCV Antibodies - RAPID 17-01-2025 05:54:PM Non Reactive HBsAg-RAPID 17-01-2025 05:54:PM Negative
RBS ON 17/1/25 -70 mg/dl. HEMOGRAM ON 17/1/25
HAEMOGLOBIN 8.2 gm/dlTOTAL COUNT 9,200 cells/cumm NEUTROPHILS 84 % LYMPHOCYTES 11 % EOSINOPHILS 04 % MONOCYTES 01 % BASOPHILS 00 % PCV 24.2 vol % M C V 84.6 fl M C H 28.7 pg M C H C 33.9 % RDW-CV 15.3 % RDW-SD 47.2 fl RBC COUNT 2.86 millions/cumm
PLATELET COUNT 3.05 lakhs/cu.mm SMEARRBC Normocytic normochromic Light MicroscopyWBC With in normal limits Light MicroscopyPLATELETS Adeqaute Light MicroscopyHEMOPARASITES No hemoparasites seen Light MicroscopyIMPRESSION Normocytic normochromic anemia
LIVER FUNCTION TEST (LFT) 17-01-2025 05:54:PMTotal Bilurubin 1.07 mg/dl 1-0 mg/dlDirect Bilurubin 0.20 mg/dl 0.2-0.0 mg/dlSGOT(AST) 15 IU/L 31-0 IU/LSGPT(ALT) 10 IU/L 34-0
IU/LALKALINE PHOSPHATASE 84 IU/L 98-42 IU/LTOTAL PROTEINS 3.9 gm/dl 8.3-6.4
gm/dlALBUMIN 2.12 gm/dl 5.2-3.5 gm/dlA/G RATIO 1.19
COMPLETE URINE EXAMINATION (CUE) 17-01-2025 05:54:PMCOLOUR Pale yellowAPPEARANCE ClearREACTION AcidicSP.GRAVITY 1.010ALBUMIN +++SUGAR NilBILE SALTS NilBILE PIGMENTS NilPUS CELLS 3-4EPITHELIAL CELLS 2-3RED BLOOD CELLS 3- 4CRYSTALS NilCASTS NilAMORPHOUS DEPOSITS AbsentOTHERS Nil
BLOOD UREA 17-01-2025 05:54:PM 49 mg/dl 42-12 mg/dl
SERUM CREATININE 17-01-2025 05:54:PM 0.8 mg/dl 1.1-0.6 mg/dl
SERUM ELECTROLYTES (Na, K, C l) 17-01-2025 05:54:PMSODIUM 136 mmol/L 145-136
mmol/LPOTASSIUM 3.8 mmol/L 5.1-3.5 mmol/LCHLORIDE 99 mmol/L 98-107 mmol/L 24 Hours Urinary Sodium ON 18/1/25 - 220 mmol/day 24 Hr URINE VOLUME : 1,700 ml
24 HOURS URINE PROTEIN ON 18/1/25- 250 mg/day. 24 HOURS URINE CREATININE-1.4 g/day RATIO 0.17URINE VOLUME 1,700 ml
24 Hr URINARYPOTASSIUM ON 18/1/25 - 45.0 mmol/day URINE VOLUME 1700 ml USG DONE ON 17/1/25
IMPRESSION:
LONG SEGMENT CIRCUMFERENTIAL WALL THICKENING OF LARGE BOWEL RIGHT ADNEXAL CYST? RIGHT OVARIAN CYST [REVIEW IN FULL BLADDER] REVIEW USG DONE ON 18/1/25
IMPRESSION:
DIFFUSE BOWEL WALL THICKENING NOTED IN ASCENDING, TRANSVERSE AND DESCENDING COLON WITH A MAXIMUM THICKNESS OF 12-13MM
MODERATE ASCITIS
B/L RAISED ECHOGENICITY OF KIDNEYS
REST OF THE FINDINGS CONSISTENT WITH THE PREVIOUS SCAN.
Treatment Given(Enter only Generic Name)
1. INJ PAN 40 MG IV /OD
2. INJ ZOFER 4 MG IV/ BD
3. INJ LASIX 40 MG IV/ BD
4. INJ. BUSCOPAN IV/SOS
5. TAB. TELMA 20 MG PO/OD/ 8 AM
6. TAB. ZYTANIX 2.5 MG PO/OD 2PM
7. SYP. MUCAINE GEL 10 ML PO/TID
8. 1 ORS SATCHET IN 1 GLASS OF WATER, DRINK 200 ML
9. OINT.THROMBOPHOBE L/A TID
10. MONITOR VITALS AND INFORM SOS
Advice at Discharge
1. TAB. PREDNISOLONE 5 MG PO/OD TO CONTINUE
2. TAB.AZATHIOPRINE 50 MG PO/OD TO CONTINUE
3. TAB. DYTOR 20 MG PO/OD TO CONTINUE
4. TAB.ZYTANIX 2.5 MG PO/OD TO CONTINUE
5. TAB.TELMA 20 MG PO/OD TO CONTINUE
6. TAB.PAN 40 MG PO/OD X 15 DAYS
7. TAB.ZOFER 4 MG PO/SOS
8. SYP. MUCAINE GEL 10 ML PO/TID X 15 DAYS
9. OINT.THROMBOPHOBE L/A TID
Follow Up
REVIEW SOS
When to Obtain Urgent Care
IN CASE OF ANY EMERGENCY IMMEDIATELY CONTACT YOUR CONSULTANT DOCTOR OR ATTEND EMERGENCY DEPARTMENT.
Preventive Care
AVOID SELF MEDICATION WITHOUT DOCTORS ADVICE,DONOT MISS MEDICATIONS. In case
of Emergency or to speak to your treating FACULTY or For Appointments, Please Contact: For Treatment Enquiries Patient/Attendent Declaration : - The medicines prescribed and the advice regarding preventive aspects of care ,when and how to obtain urgent care have been explained to me in my own language
SIGNATURE OF PATIENT /ATTENDER SIGNATURE OF PG/INTERNEE SIGNATURE OF ADMINISTRATOR SIGNATURE OF FACULTY
Discharge Date
Date: 20/1/25
Ward: FEMALE MEDICINE WARD
Unit: V
[21/01/2025, 10:15] Rakesh Biswas: What's the GFR as per this formula?
[21/01/2025, 19:11] Lupus 20F Patient Advocate: Sir akali avuthundi anme tnocha
[21/01/2025, 19:14] Patient Advocate 56F Migraine Hypothyroidism 2000: The patient is hungry, can she eat rice?
[21/01/2025, 21:13] Rakesh Biswas: Yes that's good to hear that she's feeling hungry
And if possible let her take a balanced Harvard plate
[21/01/2025, 21:15] Patient Advocate 56F Migraine Hypothyroidism 2000: Pappulu, pallu, kuralu anni thinali
[21/01/2025, 21:18] Lupus 20F Patient Advocate: Tnocha anme
[21/01/2025, 21:21] Patient Advocate 56F Migraine Hypothyroidism 2000: Anni thinachu
[21/01/2025, 22:11] Lupus 20F Patient Advocate: Nonveg tnocha
[21/01/2025, 22:12] Rakesh Biswas: Anni thinachu
Aa laga 👇
https://medicinedepartment.blogspot.com/2023/10/healthy-harvard-plate-in-telugu.html?m=1
[25/01/2025, 18:14] Rakesh Biswas: Update?
What medications is she currently on?
What is her current edema like?
[09/02/2025, 08:21] Ajay Reddy 2022 Med PG Kims: Sir the patient got admitted today morning at 6:30 am
With complains of vomitings 2 episodes at 9 pm food material as content, non bilious
Pain abdomen since 10 pm epigastric and umbilical region non radiating pain, pain is getting relieved on lying in prone position
Vitals at presentation
PR: 96/min
BP:120/70 mmHg
RR:22 cpm
Spo2:96% on RA
[09/02/2025, 13:42] Rakesh Biswas: Pancreatitis? Steroid or azathioprine induced?
Why did they not share any updates since 21st January?
[09/02/2025, 13:45] Rakesh Biswas: "The number of patients treated with azathioprine to cause an episode of pancreatitis was 36 (induction of remission) and 31 (maintenance of remission).The risk of pancreatitis in patients receiving azathioprine across all contexts was 3.80%, compared with a control risk of 0.2% (placebo) and 0.5% (5-aminosalicylic acid agents)."
Unquote
https://fg.bmj.com/content/12/5/423
[09/02/2025, 13:46] Rakesh Biswas: Azathioprine induced pancreatitis usually runs a benign self limited course with rapid disappearance of signs and symptoms upon with drawl of the drug.
Unquote
https://www.primescholars.com/articles/azathioprine-induced-pancreatitis-in-a-patient-with-coexisting-autoimmune-pancreatitis-and-hepatitis-97835.html
[09/02/2025, 13:59] Ajay Reddy 2022 Med PG Kims: On per abdominal examination there was tenderness in umbilical region sir
And the patient was also comfortable on lying in prone position
[09/02/2025, 14:01] Ajay Reddy 2022 Med PG Kims: USG showed this sir
[09/02/2025, 14:06] Rakesh Biswas: Other than inflammatory bowel disease that we had been considering for a few weeks since her first usg few weeks back showed this bowel thickening, the other important pathology to rule out is tuberculosis. @Zain Alam KIMS Pg do they do free colonoscopy there in Gandhi medical college as this patient is not affordable?
Also Ajay can you share the previous latest chest X-rays and sputum AFB and CBNAAT?
[09/02/2025, 14:09] Rakesh Biswas: Pain relieved by prone position was our initial cue to suspect pancreatitis
[09/02/2025, 14:09] Rakesh Biswas: Looks clear
[09/02/2025, 14:22] Ajay Reddy 2022 Med PG Kims: Epigastric and umbilical region pain with tenderness in umbilical region along with relief of pain on lying llin prone position or lateral position made me think pancreatitis and she also told if she drinks or eats food abdominal pain is increasing itseems sir
[09/02/2025, 14:25] Rakesh Biswas: Yes you were on the right track before the ultrasound findings added another layer of complexity
[09/02/2025, 18:03] pajr.in CEO, NHS Endocrinologist: Are we temporarily withdrawing the drug then?
[09/02/2025, 19:08] Rakesh Biswas: Yes let's keep it on hold till the uncertainty is resolved @Ajay Reddy 2022 Med PG Kims
[09/02/2025, 19:40] Ajay Reddy 2022 Med PG Kims: Okay sir
[10/02/2025, 14:39] Rakesh Biswas: Update:
Yesterday's history and ongoing meds reviewed
[10/02/2025, 14:45] Rakesh Biswas: Additional Methyl Prednisolone 500 mg iv od planned by @Dr Ramji SR Medicine today
Let's review the current status of her proteinuria with a 24 hour urine protein and creatinine.
The spot protein creatinine attached here if reliable doesn't suggest an active lupus nephritis
[10/02/2025, 14:46] Rakesh Biswas: The inflammatory bowel issue needs further investigation with a colonoscopy to rule out tuberculosis.
Let's hold the iv methyl prednisolone till then
[10/02/2025, 14:50] Rakesh Biswas: The urine output is not being monitored since admission! This is supposed to be from 9:00AM yesterday to 9:00AM today! But the patient says she voided most of it outside! @Ajay Reddy 2022 Med PG Kims @Harika CKD Anemia 2022 Project PI
[10/02/2025, 14:51] Dr Ramji SR Medicine: Sir diagnosis is clear sir..
It's mesenteric vasculitis, which is suggested by her acute presentation, favored by USG abdomen findings,delay In management can lead to complications like perforation sir...
CT abdomen is more appropriate investigation here if there is any doubt in the diagnosis sir
[10/02/2025, 14:51] Rakesh Biswas: You mean CT angiography?
[10/02/2025, 14:52] Rakesh Biswas: Get a CT angiography academic free if you suspect mesenteric vasculitis although a negative result will still not rule out micro vasculopathy
[10/02/2025, 14:53] Dr Ramji SR Medicine: No sir, CT abdomen to look for signs of vasculitis..
CT angio is not giving us much information since the vessels involved are small vessels...
[10/02/2025, 14:54] Rakesh Biswas: What signs do we expect in CT abdomen?
Can we get an Abdominal x-ray to look for any signs of intestinal obstruction?
Currently she doesn't appear to have any signs of intestinal obstruction
[10/02/2025, 14:56] Dr Ramji SR Medicine: Vessels prominence, dilated bowel loops, palisade pattern, ascites,bowel wall thickening, double halo sign
[10/02/2025, 14:57] Rakesh Biswas: Bowel thickening present in ultrasound since last two months
Ascites absent
What is the sensitivity of others?
Can one rule out intestinal vasculitis if the CT abdomen is normal?
[10/02/2025, 14:58] Rakesh Biswas: @Harika CKD Anemia 2022 Project PI please get an AxR abdomen ap view ASAP
[10/02/2025, 14:58] Dr Ramji SR Medicine: Minimal inter bowel fluid is present sir...
[10/02/2025, 15:00] Rakesh Biswas: @Harika CKD Anemia 2022 Project PI get a surgery opinion ASAP. Wasn't taken by @Ajay Reddy 2022 Med PG Kims yesterday?
[10/02/2025, 15:09] Dr Ramji SR Medicine: Ko SF, Lee TY, Cheng TT, et al.: CT findings at lupus mesenteric vasculitis, Acta Radiol 38:115–120, 1997.
[10/02/2025, 15:10] Dr Ramji SR Medicine: Article is not available for free sir, the question to sensitivity may be found in this article sir..
[10/02/2025, 15:12] Dr Ramji SR Medicine: Yesterday we managed her symptoms, while thinking of possible etiologies sir....
[10/02/2025, 15:38] Harika CKD Anemia 2022 Project PI: Okay sir
[10/02/2025, 16:01] Rakesh Biswas: Lets establish that she has intestinal obstruction with an abdominal x-ray and take the surgeons into the loop.
Let's see if a CT abdomen can be done academic free
[10/02/2025, 19:08] Rakesh Biswas: Thanks. Please get this reported by the radiology.
Please share the surgery notes
The abdominal x-ray doesn't look normal
[10/02/2025, 19:09] Harika CKD Anemia 2022 Project PI: Okay sir
The pg said she would look the case now and then will update sir
[10/02/2025, 19:50] Rakesh Biswas: Evening update:
Progressive azotemia, oliguria since morning
Urea -49 to 87
Creat -1.1 to 2.7
[10/02/2025, 20:10] Dr Ramji SR Medicine: She had significant volume loss since the onset of illness, moreover any oral correction is not tolerated by the patient sir..
Iv volume replacement was inadequate which I have asked to do strictly...
Unless her primary cause is treated, this volume loss in the form of vomiting may continue..
This is my approach towards this case sir as of now...
[10/02/2025, 20:37] Rakesh Biswas: Agree.
Can check ivc movement in inspiration and expiration using pocus ASAP @Harika CKD Anemia 2022 Project PI
[10/02/2025, 20:38] Rakesh Biswas: What is the primary cause? Unless we do a colonoscopy or CT abdomen that remains uncertain. Any luck with getting it academic free?
[10/02/2025, 20:55] Dr Ramji SR Medicine: SLE with GI vasculitis (presenting complaint)
[10/02/2025, 21:28] Pushed Communicator 1N22: Sir its looking like colon cut off sign ?
[10/02/2025, 23:55] pajr.in CEO, NHS Endocrinologist: An early Rigler sign perhaps can help?
[11/02/2025, 07:17] Rakesh Biswas: Partially.
Can't see a distinct cut off
[11/02/2025, 07:18] Rakesh Biswas: What features of the patient suggest gi vasculitis other than the fact that it's one of the differentials explaining her features of intestinal obstruction?
[11/02/2025, 08:36] Dr Ramji SR Medicine: She doesn't have substrate to suspect GI obstruction sir, pseudo obstruction is better differential
She doesn't have colicky pain, abdominal distension
Moreover already USG abdomen is done it features are suggestive of vasculitis, with involvement in 2 different sites, small bowel and large bowel..
[11/02/2025, 08:38] Dr Ramji SR Medicine: All her features are better fitting to vasculitis than obstruction sir..
[11/02/2025, 08:50] Rakesh Biswas: What usg features in her suggest vasculitis?
[11/02/2025, 08:54] Dr Ramji SR Medicine: Wall thickening, mild fluid..
[11/02/2025, 09:56] Rakesh Biswas: That can be due to any cause of inflammatory bowel
I'm writing to the MS and director in the staff group for help regarding her CT and colonoscopy
[11/02/2025, 13:28] pajr.in CEO, NHS Endocrinologist: Does she have a lupus flare now? Is Vasculitis an indication for high dose Methylpred?
I recall we do Pred 1mg/kg here
[11/02/2025, 13:35] Dr Ramji SR Medicine: It is sir..
[11/02/2025, 13:36] pajr.in CEO, NHS Endocrinologist: Alright. 👍🏼
Any literature if possible?
[11/02/2025, 14:40] Rakesh Biswas: Afternoon update and timeline by @Harika CKD Anemia 2022 Project PI
In bed
On iv NS 50 ml/hour and since morning received only 300 ml! Too less? @Harika CKD Anemia 2022 Project PI
Passed 100 ml just now!
Need
[11/02/2025, 14:43] Rakesh Biswas: The ml graduations are well visible! Simple and nice container for measuring volume from a discarded NS bottle
[11/02/2025, 14:43] Rakesh Biswas: Passed some loose stools right now
[11/02/2025, 14:47] Rakesh Biswas: Rising creatinine trends
[11/02/2025, 14:51] Rakesh Biswas: @Sai Charan Kulkarni 2020 KIMS Pg do you know anyone there in LB Nagar who can help us with the Gastro colonoscopy there?
[11/02/2025, 14:52] Tushara Reddy KIMS 2023: No one is answering the call sir i will try again later sir
[11/02/2025, 14:57] Sai Charan Kulkarni 2020 KIMS Pg: One of my batchmate in KHL is now Gastro resident in NIMS sir. Will try him
[11/02/2025, 14:59] Rakesh Biswas: Conversations with NIMs gastro resident and our ex UG PG:
[11/02, 13:12] : Can you help a 20F with intestinal obstruction with inflammatory bowel and AKI in the background of Lupus if we send her to you there just for the colonoscopy biopsy and back?
Off course if you want to admit her and go full length that also is great.
Her case report is here👇
https://pajrcasereporter.blogspot.com/2024/12/20f-lupus-nephritis-relapse-2-weeks.html?m=1
[11/02, 13:22] NIMS Gastro Kims UG PG: Is she having intestinal obstruction right now sir ?
[11/02, 13:32] NIMS Gastro Kims UG PG: Sir please ask the patient to come to nims tomorrow to meet sir. I’ll give them appointment for colonoscopy on a later date . Our schedule is full for this week already .
[11/02, 14:53]: Yes since the last few days also with AKI oliguria
Just now she feels slightly better
[11/02, 14:55]: Tomorrow in your OPD? Is it only on Wednesday?
Another 20M we had discussed with you for hypersplenism and possible portal hypertension earlier went to NIMs but couldn't meet you. Not sure which day it was
[11/02/2025, 15:03] Rakesh Biswas: I meant the conversation below from 18/1/25 but now realise we didn't actually have to administer high dose dexa then as the crisis subsided and she was discharged and forgotten without further probe with a colonoscopy.
To quote from the case report link shared above:
"PPM 2 - Are any alternatives being considered?
Does she need a pulse dosing again?
PPM 1 - This time she also appears to have an imaging finding of inflammatory bowel dose in her colon since last admission which appears to be persistent and they can't afford a colonoscopy.
Yes likely. Although iv dexa will be less taxing perhaps.
PPM 2 - I understand the imperative for this although aren't the best outcomes seen with the reliable Methylpred?
I understand each vial costs north of 1k.
PPM 1 - That's a lot.
PPM 2 - To save a kidney?
And consequently human capital?
PPM 1 - Are their studies that dexamethasone can't?
Let's try seeing if there are studies to support that imperative.
PPM 2 - Will let the treating team share.
PPM 1 - 😂
PPM 2 - No quality or reliable data comparing Dexa vs MP. May have to take some expert opinions I guess.
PPM 1 - 👍Which expert worth his salt would be spending time working in low resource settings treating lupus nephritis with dexa instead of MP?
We do have one such non expert generalist's notes documented possibly in tabula rasa. Will try to search and share.
PPM 2 - PPM 1."
[11/02/2025, 15:03] Rakesh Biswas: I guess I'll have to search my previous Lupus dexa records now
[11/02/2025, 15:18] Rakesh Biswas: 👆Found this but the original udhc.co.in disappeared before we switched to blogspot and I can't access the dexa dose details! She didn't have a bad outcome from what I can recall.
[11/02/2025, 15:22] Rakesh Biswas: 👆Finally located the dexa dose we had used!
[11/02/2025, 15:34] Rakesh Biswas: 10 years back similar Lupus patient case report with extensive engagement in tabula rasa (similar to CBBLE PaJR) 👇
https://globaludhc07.blogspot.com/2016/02/a-26-years-old-woman-with.html?m=1
[11/02/2025, 15:41] Rakesh Biswas: Can talk to NIMs Gastro and our ex UG PG.
[11/02/2025, 15:47] Rakesh Biswas: [11/02, 15:05] NIMS Gastro Kims UG PG: This week my Opd is on Wednesday and Friday sir. And for next two weeks my Opd is on Tuesday , Thursday and Saturday. They can come on any of these days when she is stable .
[11/02, 15:46] : Our PGs will text you to coordinate
[11/02/2025, 18:47] Patient Advocate 56F Migraine Hypothyroidism 2000: Can these be added in the case report?
[11/02/2025, 19:01] Rakesh Biswas: Yes that would be great if it can be done
[11/02/2025, 20:19] Patient Advocate 56F Migraine Hypothyroidism 2000: Please check the case report if everything is fine.
[11/02/2025, 20:27] Rakesh Biswas: Thanks. Yes this looks very good
[12/02/2025, 13:49] Rakesh Biswas: Given at what time?
Yesterday evening?
There was nothing mentioned in the file about it when I evaluated her in the afternoon and she had already recovered by afternoon as per my findings
[12/02/2025, 14:49] Rakesh Biswas: Saw this note now! So even when i was evaluating her at this time yesterday the iv 500mg methyl prednisolone was started by Nithin ICU PG at 3:00PM and I wasn't even informed by Nithin about it although both of us were seeing the patient together!
[12/02/2025, 15:03] Rakesh Biswas: @Nithin Chakravarthy Kims 2023 PG discarded 500 mg in that vial after giving 500 mg from the 1000mg vial
Nithin thinks as per his observations as ICU pg it's the forced ryles tube insertion followed by removal after 2-3 hours which made her recover.
@Harika CKD Anemia 2022 Project PI and @Pushed Communicator 1N22 think it could have been a pancreatitis which has recovered spontaneously and coincidentally patient also received iv methyl pred at 3:00 PM by which time she had recovered even before the methylprednisolone.
I feel while I can agree with their hypothesis, it's still possible that her supposed intestinal vasculitis was recovering slowly and yesterday's iv methylprednisolone may have helped. Again not sure how to resolve this uncertainty except to await the macroscopic colonoscopic findings and microscopic histopathology of the intestine to check what was really going on there by sending her to NIMs and hoping for the best
[12/02/2025, 15:07] Rakesh Biswas: @Harika CKD Anemia 2022 Project PI let's send her to NIMs on Friday👇
[11/02, 15:05] NIMS Gastro Kims UG PG: This week my Opd is on Wednesday and Friday sir.
And for next two weeks my Opd is on Tuesday , Thursday and Saturday. They can come on any of these days when she is stable .
[11/02, 15:46] : Our PGs will text you to coordinate
[13/02/2025, 09:10] Harika CKD Anemia 2022 Project PI: Subjectively -patient feels better compared to yesterday
But yesterday after food intake - had abdominal pain which subsided with buscopan.
No vomitings
Passed stools yesterday afternoon.
Aki in resolving trends
Urea - 110---92
Creat -2.3 ---1.4
I/o - 2900ml/650ml
For the first time yesterday night bp-150/90mm hg
And since then bp recordings -are 160/100mmhg
[13/02/2025, 09:16] Rakesh Biswas: Thanks
3 doses of methyl prednisolone over?
[13/02/2025, 09:16] Harika CKD Anemia 2022 Project PI: Today is the last dose sir
[13/02/2025, 09:16] Rakesh Biswas: What about her 24 hour protein and creatinine?
[13/02/2025, 09:31] Rakesh Biswas: Even the Lupus patient in the opposite bed had the same value?!!
[13/02/2025, 09:33] Harika CKD Anemia 2022 Project PI: Yes sir almost similar
[13/02/2025, 09:34] Rakesh Biswas: If this is true then this is the closest she has come to remission!
Now how much of that was due to her azathioprine (for which pancreatitis was one of the current differentials for her abdominal pain) and how much is due to one dose of methyl prednisolone is a big head scratcher! @pajr.in CEO, NHS Endocrinologist ?
[13/02/2025, 11:31] Rakesh Biswas: So one thing is clear after reading this that when we think of intestinal vasculitis in Lupus it needs to be before the vessels enter the intestine. In that case its difficult to explain her ultrasound findings of bowel thickening.
Also to prove Lupus intestinal vasculitis truly one may actually require laparoscopic biopsy of the affected vessels before they enter the intestine in the mesentery which in this particular patient will be very difficult to say the least.
However a colonoscopy to chase the USG bowel thickening is still worthwhile and if there's really a lesion there then a biopsy could tell a lot provided we a good coordination between endoscopist and pathologist
[13/02/2025, 14:44] Rakesh Biswas: I talked to the father who wants to go to NIMs next week on Tuesday, Thursday or Saturday.
@Harika CKD Anemia 2022 Project PI can you also get a rough estimate of the potential costs from Srujan
[13/02/2025, 15:05] Harika CKD Anemia 2022 Project PI: Yes sir I spoke with sir
He said that he will be available on Tuesday Thursday and Saturday
Since they will be discharged tomorrow
I think they can go on Tuesday sir to have an appointment for the later date
And colonoscopy would cost around 2.5k
With biopsy -rs.700 sir
Approx 3.4-4k would be an estimate sir
[14/02/2025, 15:14] Rakesh Biswas: @Dr Ramji SR Medicine as a cyclic iv pulse cyclophosphamide is being planned for her under your guidance, it would be great if you can share any good RCT that shows efficacy of that regime vs other care
@Sai Charan Kulkarni 2020 KIMS Pg would be nice if you too could share
[14/02/2025, 15:49] Rakesh Biswas: Her BP spikes are an effect of iv methyl prednisolone or lupus nephritis?
[14/02/2025, 16:17] Dr Ramji SR Medicine: I'm unavailable today for discussion sir...
[14/02/2025, 19:54] Tushara Reddy KIMS 2023: The abdomen is distended now sir visually
Yesterday the abdominal girth is 69 cms
Today eve it is 73 cms sir
She did not pass stools today
[14/02/2025, 21:43] Rakesh Biswas: Thanks.
Let's hope we get her colonoscopy quickly before she again goes into another obstruction
[15/02/2025, 14:34] Dr Ramji SR Medicine: Our patient is having loose stools due to laxative sir, she is not feeling well, so instructed our PG's to postpone plan for discharge and counseled the attenders too about the same sir..
Goal is make her fit for colonoscopy guided biopsy on Tuesday.. @Rakesh Biswas...
[19/02/2025, 18:38] Lupus 20F Patient Advocate: Gd evng sir nd madam tblts m chepaldu gaa
[19/02/2025, 19:11] Rakesh Biswas: Please share the tablets your patient is currently taking. Her colonoscopy is planned on Friday.
Please ask her to continue the tablets she was previously taking till we get her colonoscopy report
[19/02/2025, 19:12] Rakesh Biswas: @pajr.in CEO, NHS Endocrinologist Srujan texted. He'll also try to get her colonoscopy bill waived. They may have to pay for the pathology bill. I guess that would be great.
[19/02/2025, 20:19] Harika CKD Anemia 2022 Project PI: Yes sir they visited and they are scheduled on Friday for colonoscopy
They have doubt regards what medications to continue and have cleared them sir
[21/02/2025, 16:17] Rakesh Biswas: Update:
The colonoscopy mucosa appeared normal?
Could it have been an intestinal vasculitic flare up that gave rise to her intestinal obstruction symptoms then?
[21/02/2025, 16:18] Harika CKD Anemia 2022 Project PI: Vasculitic flare up only supports it i think so sir
[21/02/2025, 16:20] Rakesh Biswas: Yes! @Dr Ramji SR Medicine
[21/02, 16:18] NIMS Gastro Kims UG PG: The mucosa upto the terminal ileum was normal sir . Vasculitic flare is one possibility and the other may be small bowel strictures which cause intermittent obstruction too . As she is asymptomatic now , it would be better to get a cect enterography the next time she gets any features if obstruction . We did take biopsy just in case
[21/02/2025, 17:52] Dr Ramji SR Medicine: Acute on Chronic vasculitis with strictures causing pseudo obstruction sir...
[24/02/2025, 09:49] Ajay Reddy 2022 Med PG Kims: Patient admitted today morning with complains of vomitings since 4 am 4-5 episodes
1 st episode was some of the food contents and watery .
Next episodes patient complains of hematemesis - dark colored
No complains of pain abdomen, constipation, fever
Vitals on presentation
Pr : 92/min
BP: 110/70 mmHg
Spo2: 95 on RA
Rr:22 cpm
P/A : soft, non tender
[24/02/2025, 09:51] Dr Ramji SR Medicine: Have they taken any photo of haematemesis??
[24/02/2025, 09:52] Dr Ramji SR Medicine: How sure you are it's haematemesis??
[24/02/2025, 09:56] Rakesh Biswas: Any maintenance prednisolone she was on at discharge?
[24/02/2025, 14:28] Ajay Reddy 2022 Med PG Kims: Yes sir
She is on prednisolone 10 mg po od, tab. Azathioprine 50 mg po od
[24/02/2025, 19:34] Rakesh Biswas: I checked in the afternoon. Although we had written 10 they were taking 5 but I guess that's okay and may not be responsible for hypoadrenalism causing her current symptoms.
Drug induced gastritis is the other possibility for which we shall get her upper GI endoscopy tomorrow
[25/02/2025, 10:56] Rakesh Biswas: Update:
BP charting since 4:00PM revealed higher spikes 140/100 to 150/100 and night 7:30 PM took Telma 40 and hourly BP monitoring slightly relented although today it's again higher before her planned upper GI endoscopy. @Ajay Reddy 2022 Med PG Kims we'll also need to review her 24 hour urinary protein and creatinine which for the first time had shown near remission of her lupus nephritis during last admission
[26/02/2025, 22:18] Rakesh Biswas: Current problem:
Persistent vomiting immediately after food
Invite inputs @pajr.in CEO, NHS Endocrinologist @Sai Charan Kulkarni 2020 KIMS Pg @Dr Ramji SR Medicine
[26/02/2025, 22:20] Dr Ramji SR Medicine: I shall give my inputs tomorrow sir after talking to the patient..
[26/02/2025, 22:46] Sai Charan Kulkarni 2020 KIMS Pg: Given her complaints :
22F immunosuppressive with acute to sub acute abdominal pain and vomitings with Flare up of Lupus nephritis. With background of endocarditis
*assuming Normal UGIE attached above
Localisation -
GI -
1. Mesentric ischemia / intestinal angina
2. Lupus enteritis / Vasculitis ( sub acute ) - associated with flare up of LN
2. IBD
3. ischemic colitis ( ?mesentric vessels occlusion again )
? External compression of bowel or blood vessel
Renal - azotemia / ?middle molecules triggering CTZ
CNS- raised ICP ( less likely )
@Ajay Reddy 2022 Med PG Kims did we do her CT angio..? Or CECT abd..?
[26/02/2025, 22:49] PI Portal Hypertension Project 2022: Cect abd or CT angio was not done sir
[26/02/2025, 22:50] pajr.in CEO, NHS Endocrinologist: How would they help?
[26/02/2025, 22:50] pajr.in CEO, NHS Endocrinologist: Why not drug induced? Vomiting immediately after eating?
[26/02/2025, 22:52] Sai Charan Kulkarni 2020 KIMS Pg: Yes sir possible. She is been on AZA which could cause pancreatitis too.
[26/02/2025, 22:52] PI Portal Hypertension Project 2022: https://pmc.ncbi.nlm.nih.gov/articles/PMC8214088/
[26/02/2025, 22:53] pajr.in CEO, NHS Endocrinologist: Yeah. So maybe Lipase with a USG should suffice for now?
[26/02/2025, 22:53] pajr.in CEO, NHS Endocrinologist: Relevant bits please.
[26/02/2025, 22:53] PI Portal Hypertension Project 2022: One of our faculty was thinking it could be cyclic vomiting syndrome as a differential sir
[26/02/2025, 22:54] pajr.in CEO, NHS Endocrinologist: Isn't that a diagnosis of exclusion and is usually not sinister as seen here?
[26/02/2025, 22:55] Sai Charan Kulkarni 2020 KIMS Pg: Rather colonoscopy would be better.
Look for any signs of bowel inflammation or ischemia or an ulcers and take a bit for histopathology.
[26/02/2025, 22:56] pajr.in CEO, NHS Endocrinologist: Vomiting immediately after food intake would localise the problem much higher wouldn't it? Which means the problem is involving the digestive machinery - esophagus, stomach, hepato-pancreatico-biliary organs?
[26/02/2025, 22:59] pajr.in CEO, NHS Endocrinologist: I wish I had WhatsApp AI but can you please ask what is the incidence of vomiting in patients taking Azathioprine?
[26/02/2025, 22:59] Sai Charan Kulkarni 2020 KIMS Pg: @Meta AI incidence of vomitings in patients in chronic azathioprine
[26/02/2025, 22:59] Meta AI: Azathioprine is an immunosuppressive medication commonly used to treat autoimmune diseases, prevent organ rejection in transplant patients, and manage certain inflammatory conditions.
Regarding the incidence of vomiting in patients taking chronic azathioprine, here are some findings:
- A study published in the Journal of Clinical Pharmacology found that gastrointestinal symptoms, including nausea and vomiting, occurred in approximately 12% of patients taking azathioprine (1).
- Another study published in the British Journal of Clinical Pharmacology reported that vomiting was experienced by around 5% of patients receiving azathioprine (2).
- A review of azathioprine's safety profile published in the journal Expert Opinion on Drug Safety noted that gastrointestinal adverse effects, including vomiting, are relatively common, affecting up to 20% of patients (3).
Please note that the incidence of vomiting can vary depending on factors such as:
- Dosage: Higher doses may increase the risk of gastrointestinal side effects.
- Individual tolerance: Some patients may be more susceptible to azathioprine's side effects.
- Concomitant medications: Taking other medications that can cause gastrointestinal upset may increase the risk of vomiting.
If you're experiencing persistent or severe vomiting while taking azathioprine, it's essential to consult your healthcare provider for proper evaluation and guidance.
References:
1. Journal of Clinical Pharmacology, "Azathioprine-induced gastrointestinal symptoms: a review of the literature" (2018)
2. British Journal of Clinical Pharmacology, "Adverse effects of azathioprine in patients with inflammatory bowel disease" (2015)
3. Expert Opinion on Drug Safety, "Azathioprine: a review of its safety profile" (2019)
I hope this helps! If you have further questions or concerns, feel free to ask.
[26/02/2025, 23:00] pajr.in CEO, NHS Endocrinologist: Please ask absolute numbers and duration of Azathioprine in study 1
[26/02/2025, 23:03] PI Portal Hypertension Project 2022: @Meta AI absolute numbers and duration of Azathioprine in study 1
[26/02/2025, 23:03] Meta AI: In Study 1, the absolute numbers and duration of Azathioprine were as follows:
- *Number of patients*: 40 children with inflammatory bowel disease (IBD) ¹
- *Duration of Azathioprine treatment*: The study doesn't explicitly state the duration, but it mentions that thiopurines can take up to 14 weeks to be fully effective ¹
- *Azathioprine dose*: The mean azathioprine dose was 1.3±0.4 mg/kg ¹
- *Thiopurine metabolite measurement timing*: Blood tests were performed 6 weeks after the initiation of therapy ¹
[26/02/2025, 23:10] Sai Charan Kulkarni 2020 KIMS Pg: @pajr.in CEO, NHS Endocrinologist @PI Portal Hypertension Project 2022
Incidence of Vomiting in Chronic Azathioprine Use: A Comprehensive Analysis of Large-Scale Medical Studies
Azathioprine, a widely used immunosuppressive agent, has demonstrated clinical efficacy across various autoimmune and inflammatory conditions. However, its therapeutic benefits are often accompanied by gastrointestinal adverse effects, with vomiting representing a clinically significant concern. This report synthesizes data from multiple large-scale studies to quantify the incidence of vomiting during chronic azathioprine therapy, providing granular insights into population-specific risks, dose dependencies, and management strategies.
---
## Epidemiological Overview of Azathioprine-Associated Vomiting
The incidence of vomiting during azathioprine therapy varies substantially across patient populations and treatment protocols. A landmark study involving **622 inflammatory bowel disease (IBD) patients** revealed that **68 patients (10.9%)** discontinued treatment due to nausea and vomiting, with symptoms typically emerging within a mean of **106 days** after initiation[6]. Notably, this cohort received a mean dose of **1.77 mg/kg/day**, though no direct correlation between dose intensity and emetic frequency was observed[6]. These findings align with a Korean pediatric IBD study where **27 of 174 patients (15.5%)** experienced vomiting at a mean dose of **1.38 mg/kg/day**, with **10 patients (5.7% of total cohort)** requiring permanent discontinuation[3][5].
---
## Dose-Response Relationships and Temporal Patterns
Contrary to conventional pharmacokinetic expectations, vomiting incidence does not exhibit strong dose dependency. In the Korean pediatric cohort, vomiting occurred across a broad dose range (**1.38 ± 0.46 mg/kg/day**), with symptom onset delayed until a mean of **10.4 months** into therapy[3]. This contrasts with adult populations where emetic episodes frequently manifest earlier, suggesting age-related differences in drug tolerance. A paradoxical observation emerged from a 14-patient gastritis study, where only **1 patient (7.1%)** developed dose-limiting nausea/vomiting despite prolonged azathioprine exposure (>2.5 months)[2], highlighting condition-specific variability in adverse effect profiles.
---
## Population-Specific Risk Stratification
### Pediatric vs. Adult Populations
Pediatric patients demonstrate heightened vulnerability, with **15.5% vomiting incidence** in Korean children[3] versus **10.9%** in mixed-age IBD cohorts[6]. This disparity may reflect developmental differences in thiopurine methyltransferase (TPMT) activity or enterohepatic recirculation patterns. Notably, pediatric data showed **37% of vomiting cases** required dose reduction, while adults predominantly required complete cessation[3][6].
### Disease-State Modifiers
IBD patients exhibit higher emetic rates (**10.9-15.5%**[3][6]) compared to transplant recipients (<1%[4]). This discrepancy likely stems from baseline gastrointestinal inflammation in IBD exacerbating drug-induced mucosal irritation. A critical finding from the 622-patient IBD study revealed **64% remission rates** in Crohn's disease patients persisting beyond six months of therapy despite vomiting incidence[6], underscoring the risk-benefit calculus in chronic management.
---
## Management Algorithms and Clinical Outcomes
### Pharmacological Interventions
Proactive antiemetic use remains controversial due to potential drug interactions. The NHS guidelines recommend dietary modifications (e.g., administration with meals) as first-line management, reporting symptom resolution within one week for most patients[1]. Refractory cases often necessitate dose reduction, successful in **29.6% of pediatric patients**[3], though this risks subtherapeutic immunosuppression.
### Discontinuation Thresholds
Permanent cessation rates vary by indication:
- **5.7%** in pediatric IBD[3]
- **10.9%** in adult IBD[6]
- **7.1%** in chronic gastritis[2]
Notably, **17% of adult IBD patients** restarting azathioprine after initial intolerance achieved long-term tolerance through gradual dose escalation[6], suggesting protocolized rechallenge strategies may mitigate attrition.
---
## Mechanistic Considerations in Emetogenesis
The dual-phase vomiting pathophysiology involves:
1. **Direct mucosal irritation** via 6-thioguanine nucleotide accumulation in gut epithelium[4]
2. **Central chemoreceptor activation** through proinflammatory cytokine cross-talk (IL-6, TNF-α)[3]
Hepatic metabolism polymorphisms further modulate risk, with slow TPMT metabolizers showing **3.2-fold increased emetic propensity** in pharmacogenetic subanalyses[6]. These insights inform emerging genotype-guided dosing protocols aiming to balance efficacy and tolerability.
---
## Longitudinal Safety Data
The 622-patient cohort provided critical temporal insights:
- **42.3% of vomiting cases** occurred within 3 months
- **28.1%** manifested between 3-12 months
- **29.6%** emerged after >1 year of therapy[6]
This prolonged risk window contradicts traditional "early toxicity" paradigms, necessitating ongoing monitoring even in long-term users. Late-onset cases correlated with cumulative dose thresholds exceeding **200g**, suggesting mitochondrial toxicity mechanisms[4].
---
## Comparative Safety Profiles
While vomiting represents a predominant gastrointestinal effect, its incidence eclipses other azathioprine toxicities:
- **4.6% leukopenia**[6]
- **7.5% pancreatitis**[3]
- **2.9% hepatotoxicity**[3]
Notably, **68% of drug discontinuations** stem from vomiting/nausea compared to **4.6% for hematologic effects**[6], emphasizing its clinical impact on treatment adherence.
---
## Conclusion: Risk Mitigation in Clinical Practice
Synthesizing data from 796 patients across three continents, chronic azathioprine therapy carries a **11-15% vomiting risk**, with absolute case numbers ranging from **68/622**[6] to **27/174**[3] in large cohorts. Proactive genotype screening (TPMT, NUDT15), staggered dosing protocols, and early antiemetic support may reduce attrition. Future research should prioritize randomized trials of aprepitant and olanzapine as prophylactic agents in high-risk populations.
Sources
[1] Side effects of azathioprine - NHS https://www.nhs.uk/medicines/azathioprine/side-effects-of-azathioprine/
[2] The effect of azathioprine on gastric mucosal histology and acid ... https://pubmed.ncbi.nlm.nih.gov/4696531/
[3] Adverse Events Associated with Azathioprine Treatment in Korean ... https://pmc.ncbi.nlm.nih.gov/articles/PMC3819691/
[4] Azathioprine Side Effects: Common, Severe, Long Term - Drugs.com https://www.drugs.com/sfx/azathioprine-side-effects.html
[5] [PDF] Adverse Events Associated with Azathioprine Treatment in Korean ... https://www.pghn.org/Synapse/Data/PDFData/1121PGHN/pghn-16-171.pdf
[6] The efficacy of azathioprine for the treatment of inflammatory bowel ... https://pmc.ncbi.nlm.nih.gov/articles/PMC1773162/
[7] Long -term safety and toxicity of azathioprine in patients with air ... https://ijdvl.com/long-term-safety-and-toxicity-of-azathioprine-in-patients-with-air-borne-contact-dermatitis/
[8] [PDF] Azathioprine (Imuran) https://www.cuh.hse.ie/media/pil/azathioprine-imuran-gp-sheet-2023.pdf
[9] Effect of azathioprine intolerance on outcomes of inflammatory ... https://pmc.ncbi.nlm.nih.gov/articles/PMC5369706/
[10] Hypersensitivity to azathioprine in a patient with Crohn's disease http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082017001000013
[11] Long‐term safety and effectiveness of azathioprine in the ... https://onlinelibrary.wiley.com/doi/full/10.1002/jgh3.12955
[12] azathioprine oral: Uses, Side Effects, Interactions, Pictures ... - WebMD https://www.webmd.com/drugs/2/drug-13771/azathioprine-oral/details
[13] Azathioprine (Imuran®) Drug Information Sheet https://www.hopkinsarthritis.org/patient-corner/drug-information/azathioprine-imuran/
[14] [PDF] 787fm.3 azathioprine for use in rheumatology, dermatology https://www.bucksformulary.nhs.uk/docs/Guideline_787FM.pdf
[15] Azathioprine (oral route) - Mayo Clinic https://www.mayoclinic.org/drugs-supplements/azathioprine-oral-route/description/drg-20067180
[16] Long-term Efficacy and Safety of Azathioprine in Ulcerative Colitis https://academic.oup.com/ecco-jcc/article/9/2/191/439760
[17] [PDF] updated azathioprine guidelines. - London - Whittington Hospital https://www.whittington.nhs.uk/document.ashx?id=6404
[18] Azathioprine (Imuran®) Uses and Side Effects https://www.chp.edu/our-services/transplant/liver/education/medications/azathioprine-imuran
[19] Weekly azathioprine pulse versus daily azathioprine in the treatment ... https://ijdvl.com/weekly-azathioprine-pulse-versus-daily-azathioprine-in-the-treatment-of-parthenium-dermatitis-a-non-inferiority-randomized-controlled-study/
[20] Azathioprine: Side Effects, Dosage, Uses, and More - Healthline https://www.healthline.com/health/drugs/azathioprine-oral-tablet
[21] Azathioprine - StatPearls - NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK542190/
[22] Azathioprine: Side Effects & Treatment - Cleveland Clinic https://my.clevelandclinic.org/health/drugs/9407-azathioprine
[23] Azathioprine | Side-effects, uses, time to work - Versus Arthritis https://versusarthritis.org/about-arthritis/treatments/drugs/azathioprine/
[24] Toxicity of azathioprine: why and when? analysis of the prevalence ... https://www.scielo.br/j/ag/a/f9L5FC63GsTFFxvJsZ3TrrN/
[25] Real-World Study Finds Long-Term Azathioprine Treatment Safe ... https://www.managedhealthcareexecutive.com/view/real-world-study-finds-long-term-azathioprine-treatment-safe-effective-in-patients-with-ibd
[26] Long‐term safety and effectiveness of azathioprine in the ... https://pmc.ncbi.nlm.nih.gov/articles/PMC10517446/
[27] Azathioprine in ulcerative colitis: Why, when, how and how long to ... https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/ddr.20481
[28] [PDF] Azathioprine for patients within adult services (non-transplant ... https://www.covwarkformulary.nhs.uk/docs/chapter01/SCA102-Azathioprine%20non%20transplant%20indications.pdf
[26/02/2025, 23:18] PI Portal Hypertension Project 2022: According to the above study, azathioprine causes vomiting in 10-15% patients sir
[26/02/2025, 23:29] Ajay Reddy 2022 Med PG Kims: Lipase done during previous admission was normal sir
[26/02/2025, 23:33] PI Portal Hypertension Project 2022: She had similar complaints at that time too sir, Lipase was normal
[27/02/2025, 07:30] Rakesh Biswas: Can't trust meta AI or any LLM unless one can actually read the data in a real journal. LLMs are notorious for confabulating
However having said that I guess we should stop azathioprine for now
Please let me know if urine 24 protein and creatinine was collected yesterday and sent today to determine if her lupus nephritis is now in remission or not at least similar to what we found in her last admission
[27/02/2025, 16:17] Rakesh Biswas: [27/02, 14:35] pg: Can we plan renal biospy for her sir?!
[27/02, 16:15] pm: Yes we discussed that today in the afternoon rounds.
Problem is her Lupus nephritis isn't one of the current pressing problems although because her immunosuppressives are getting a bit irregular due to the side effects, the latest suspect for her vomiting is azathioprine induced pancreatitis, her current 24 hour proteinuria has again increased from insignificant the last time few weeks back from 200 mg to 900 mg today
So it's essentially a tight rope between balancing the side effects of her immunosuppressives vs her lupus nephritis, which is compounded by total loss of follow up due to our inability to communicate with her family till she gets readmitted with a crisis!
Now that we have stopped her azathioprine we have to quickly think of an alternative immunosuppressive adjuvant. The last time we rejected mycofenolate in favour of azathioprine was due to cost consideration and also it can cause diarrhoea but I guess Diarrhoea is preferable to pancreatitis and vomiting!
[27/02/2025, 16:58] Harika CKD Anemia 2022 Project PI: Yesterday -2000/400ml
[27/02/2025, 16:58] Rakesh Biswas: Day before?
[27/02/2025, 16:59] Rakesh Biswas: Today's?
[28/02/2025, 09:20] Tushara Reddy KIMS 2023: 1050/200 ml on 26 th sir
[28/02/2025, 09:20] Tushara Reddy KIMS 2023: Today -1100/250 ml sir
[28/02/2025, 09:27] Rakesh Biswas: You mean yesterday's 24 hour urine output was 250 ml?
Last serum creatinine?
[28/02/2025, 12:27] Harika CKD Anemia 2022 Project PI: Sir till evening there was no output
She is dehydrated
And after iv fluids- urine output was 250ml sir
Slightly better compared to yesterday
2 episodes of vomitings
Pain abdomen+
Tenderness in the epigastric region.
No fever spikes
Has passed stools yesterday
S.creat -1.0
[28/02/2025, 13:14] Rakesh Biswas: Yes let's monitor the urine output hourly and replenish her volume hourly as per our hourly evaluation of her ivc mobility
[28/02/2025, 14:24] Rakesh Biswas: @Sai Charan Kulkarni 2020 KIMS Pg you recall once at the beginning we had tried to start her on mycofenolate mofetil vs azathioprine and @Deepika Kims Med PG 2021 also reviewed the literature on azathioprine vs mycofenolate efficacy here following which we started her on azathioprine as the efficacies and adverse effects appeared comparable.
We now know that azathioprine has been stopped on suspicion of pancreatitis and we have to start on mycofenolate so @Pushed1Comm22 just looked up the prize differences and while mycofenolate is 70 per tablet, azathioprine is 12/- per tablet
[28/02/2025, 15:55] Sai Charan Kulkarni 2020 KIMS Pg: Yes sir our team collectively decided to start her on AZA due to low cost with similar efficacy.
[28/02/2025, 15:59] Sai Charan Kulkarni 2020 KIMS Pg: Yes sir this is from perplexity, analysed by chain of thought and step by step analysis. Agreed A.I. hallucination can’t be ruled out especially in consolidating large studies. But prompts used will alter the results of reasoning sir.
[01/03/2025, 08:19] Dr Ramji SR Medicine: In summary, the cumulative exposure to CYC that
results in ovarian failure varies by age. To avoid
amenorrhea, female patients < 20 years old should
likely receive < 15 to 20 g of total exposure, patients
aged 20 to 30 should receive < 15 g of total exposure
and those > 30 should likely receive < 10 g of total
exposure. We did not make a recommendation for
maximum exposure to prevent infertility in patients
> 40 as this group already has a low baseline fertility
rate, worsened by disease activity. In males, the
maximum CYC exposure for patients who still wish to
conceive is lower at approximately 10 g.
[01/03/2025, 08:23] Dr Ramji SR Medicine: We are just calculating the cost of tablets sir. Length of hospital stays, recurrent admissions, burden on the family members with these recurrent admissions also should be taken into consideration..
[01/03/2025, 08:25] Rakesh Biswas: Agree! Well said 👏
[01/03/2025, 08:26] Rakesh Biswas: So the harms appear to be worth a try!
Please share the efficacy and let's see if it beats the efficacy and harms of mycofenolate mofetil
[01/03/2025, 08:28] Rakesh Biswas: As a comparison, this patient swallowed 19.5 gms of azathioprine before developing what we currently believe is pancreatitis since few weeks!
[01/03/2025, 08:31] Dr Ramji SR Medicine: Selection of drug principally relies on renal biopsy along with other disease activity parameters sir...
So even if a drug is chosen it is chosen out of presumption only.. Not completely evidence based...
In other words we are starting a new experiment, without proving the previous experiments(recommendations) are trash or not working....
[01/03/2025, 08:34] Dr Ramji SR Medicine: We are repeating lipase today sir...
Specificity of lipase is roughly 99 %...
We have to await for lipase results to say it's pancreatitis...
[01/03/2025, 08:37] Dr Ramji SR Medicine: One thing is very clear sir, she is having disease activity, and requires immunosuppression immediately, then planned for renal biopsy for definitive decision making.
[01/03/2025, 08:48] Rakesh Biswas: Specificity may not be as important as sensitivity here in this case who already had demonstrated normal lipase during her previous acute attack during her previous admission!
Sensitivity is more important because if it's negative we will still not be able to rule it out as it's known to have sensitivity varying from 64-100%
Here's a paper citing the same including the fact that even specificity isn't 100% for pancreatitis as IBD can often have high lipase!
https://www.sciencedirect.com/science/article/pii/S1365182X1531176X
[01/03/2025, 08:51] Rakesh Biswas: Agree that she has disease activity and we have been able to suppress it using drugs in the past unfortunately that we are having to discontinue because of cumulative side effects.
In view of no definitive data toward cyclophosphamide which will also need to be discontinued after a few months, i would prefer starting mycofenolate mofetil albeit expensive
However if there is good evidence of a cyclophosphamide pulse showing complete remission without recurrence it could be worth considering. However we need to see the evidence for it. @Sai Charan Kulkarni 2020 KIMS Pg would you like to try perplexity again for this?
[01/03/2025, 09:13] Dr Ramji SR Medicine: I'm thinking that patient has less probability of pancreatitis sir..
Both sensitivity and specificity are high for lipase..
Helps to both rule out, as well as rule in with almost certainty....
[01/03/2025, 09:18] Rakesh Biswas: Sensitivity can vary from 64-100%
Negative doesn't rule out
[01/03/2025, 09:19] Rakesh Biswas: What is our alternate diagnosis for her symptoms?
[01/03/2025, 09:20] Dr Ramji SR Medicine: Though not meeting the cutoff, I'm convinced that patient is having pancreatitis sir...
Withholding azathioprine is justified sir...
[01/03/2025, 09:21] Dr Ramji SR Medicine: Considering her symptoms examination findings and elevation in enzymes...
[01/03/2025, 09:25] Rakesh Biswas: What was her previous amylase lipase during the last admission managed by @Ajay Reddy 2022 Med PG Kims where our first clinical impression was pancreatitis but we kind of gave it up once the enzymes didn't support that hypothesis
[01/03/2025, 09:36] Ajay Reddy 2022 Med PG Kims: Previous admission lipase was 24 IU/L sir
[01/03/2025, 09:44] Rakesh Biswas: An important learning point worth exploring further here in a thesis project here would be the variability of enzymatic activity in pancreatitis and how a longitudinal follow up is necessary for diagnosis rather than just a few random values? @Sai Charan Kulkarni 2020 KIMS Pg @pajr.in CEO, NHS Endocrinologist ?
[01/03/2025, 16:39] Rakesh Biswas: Thanks @Sai Charan Kulkarni 2020 KIMS Pg
@Dr Ramji SR Medicine @pajr.in CEO, NHS Endocrinologist if you go through these inputs from AI in the context of our patient, our patient has already demonstrated achievable remission induction in her last visits with proteinuria touching 200 mg near remission. The issue was with maintenance and while she was lucky with the remission front with steroids and azathioprine she developed pancreatitis and hence we just need to switch into another modality to reinstate remission and maintain it.
The trouble with cyclophosphamide is the cumulative gonadal toxicity so we can use it to achieve remission to begin with even using oral now and then once we reach the gonadal cumulative limit as well as document remission in the coming three months we can then switch to the expensive mycofenolate mofetil?
[01/03/2025, 20:47] Sai Charan Kulkarni 2020 KIMS Pg: My critical thought is to educate attenders regarding cumulative side effects of cyclophosphamide and expensiveness of MMF for maintainance therapy and efficacies of both. Let them understand the current complexities in therapeutic decision making and let them be part of this process sir.
[03/03/2025, 03:40] pajr.in CEO, NHS Endocrinologist: https://pubmed.ncbi.nlm.nih.gov/9436862/
"In the serum samples collected on days 0-1 after the onset of symptoms, lipase was elevated in 100% and amylase in 95%. A 95% sensitivity/specificity was reached at a lipase cutoff near twofold above normal. The receiver-operating characteristics (ROC) showed similar curves for both enzymes, lipase being slightly superior to amylase. The ROC curves from days 2-3 demonstrated a much lower sensitivity/specificity of both enzymes. Lipase, however, was notably superior to amylase: at a sensitivity of 85% the specificity of lipase (amylase) was 82% (68%). In samples from days 4-5 the accuracy of the enzyme assays was even worse; at a sensitivity of 60% the specificity did not increase above 70%."
[03/03/2025, 08:09] Rakesh Biswas: Beautiful! Just as we suspected!
[23/03/2025, 12:50] Lupus 20F Patient Advocate: Gd afternoon sir and madam ninna iron tblt vesukunna ninna 1time vomtings aenae eroju moham kadupu vampu vchindi
[23/03/2025, 13:41] Patient Advocate 56F Migraine Hypothyroidism 2000: The patient has taken iron tablet yesterday and had vomiting once. Today she has facial swelling and bloating stomach
[23/03/2025, 17:54] Rakesh Biswas: Let her hold the iron tablets for now.
When did she start taking them?
[23/03/2025, 17:55] Sai Charan Kulkarni 2020 KIMS Pg: Since Yesterday sir, told to withhold as of now.
[23/03/2025, 17:56] Rakesh Biswas: Why yesterday!
[23/03/2025, 18:28] Sai Charan Kulkarni 2020 KIMS Pg: Yesterday patient father called me inview of nausea and vomiting after taking iron tablet which was taken yesterday first time after discharge. Reassured and advised to stop iron tablet as of now sir
[06/04/2025, 18:40] Harika CKD Anemia 2022 Project PI: @Lupus 20F Patient Advocate ela unnaru
Follow up ki epudu ostavu
[06/04/2025, 18:41] Lupus 20F Patient Advocate: Nice madam 12 ki vastha madam
[12/04/2025, 12:04] Rakesh Biswas: Reviewing now in OPD:
Asymptomatic after her last debacle when we had to admit her for recurrent abdominal pain and then stop her azathioprine assuming it's azathioprine induced recurrent pancreatitis!
Same sitting we also did her renal biopsy and now that she was out of sight and out of mind for a month we suddenly realised we didn't see that report! @Pushed1Comm22 @Pushed Communicator 1N22
[12/04/2025, 12:07] Rakesh Biswas: She's moving around with the tissue blocks which appears to have been provided to her by the Nalgonda lab where it was deposited!
Now please let's show these blocks to our pathology lab here in Narketpally campus
[12/04/2025, 12:22] Rakesh Biswas: Talked to the father just now @Harika CKD Anemia 2022 Project PI @Dr Ramji SR Medicine
He deposited the renal biopsy tissue in that Nalgonda lab and paid the money but didn't collect any bill and yesterday once he reached that lab for the report they simply handed him this packet containing blocks!
[12/04/2025, 12:32] Pushed Communicator 1N22: Sir the pathologist at nalgonda said she usually dont report renal biopsy
So she sent back the blocks asking them to get reported at other center
[12/04/2025, 12:33] Rakesh Biswas: This is terrible isn't it! 😨
[12/04/2025, 12:34] Pushed Communicator 1N22: We asked the attender to collect the report multiple times in the past few weeks sir
We thought they are a bit busy and will come to us with the report
[12/04/2025, 12:39] Harika CKD Anemia 2022 Project PI: Yes sir that tooo after repeated calls and msgs they went yesterday to collect the report sir
[12/04/2025, 12:41] Sai Charan Kulkarni 2020 KIMS Pg: In which lab sample was given Govt lab or Raju @ thyrocare..?
[12/04/2025, 12:41] Vivek Kurma 2022 KIMs Pg Med: Jagruthi diagnostics sir
[12/04/2025, 12:43] Pushed Communicator 1N22: At Thyrocare
They dont prepare the blocks and slides sir
[12/04/2025, 12:44] Sai Charan Kulkarni 2020 KIMS Pg: Usually we send biopsy samples to KHL right..? What made us to out source sample this time..?
[12/04/2025, 12:46] Vivek Kurma 2022 KIMs Pg Med: Contacted thyrocare now sir they said they give report after 1 week with cost of 800 sir
[12/04/2025, 12:46] Rakesh Biswas: Why didn't we verify that Jagruti diagnostics doesn't do renal biopsy reporting?
[12/04/2025, 12:47] Rakesh Biswas: Now we are sending the blocks to our campus pathology. Not sure how much they charge
[12/04/2025, 12:48] Vivek Kurma 2022 KIMs Pg Med: Khl costs around 3k sir whereas in NLG it is costing around 1500 sir
[13/04/2025, 14:21] Rakesh Biswas: What about Narketpally?
To KHL we can send just the immuno florescence part?
Also from what we know now there's no expertise in Nalgonda to see these histopathology specimens particularly renal biopsy. I'm sure we may have a better light microscopy expertise here in Narketpally
[13/04/2025, 14:22] Rakesh Biswas: Why didn't we talk to Dr Krishna Chaitanya and ask where he would prefer to send his biopsies or where does he send his biopsies that he does in other centres
[17/04/2025, 11:23] Rakesh Biswas: Update:
Ultimately the biopsy was still sent to this lab instead of our own Narketpally lab!
[02/05/2025, 20:41] Rakesh Biswas: So @Sai Charan Kulkarni 2020 KIMS Pg @pajr.in CEO, NHS Endocrinologist is this Lupus nephritis class 2 or class 4?
[02/05/2025, 21:14] Sai Charan Kulkarni 2020 KIMS Pg: Yes sir mesangioproliferative in favour of grade 2 LN.
[02/05/2025, 21:15] Rakesh Biswas: So why did we/you have to treat her as class 4 Lupus at some point in 2022 end when she first presented to us?
[02/05/2025, 21:51] pajr.in CEO, NHS Endocrinologist: Clinical severity?
[02/05/2025, 22:15] Rakesh Biswas: Clinical class 4 reverting to class 2 or clinico pathologic dys-correlation?
[02/05/2025, 22:26] pajr.in CEO, NHS Endocrinologist: Likely the former.
[06/05/2025, 17:01] Rakesh Biswas: Update:
Admitted yesterday with vomiting and reduced appetite since 2-3 weeks after she stopped the prednisolone on her own and continued only the MMF!
@Akash Deep Kims 2023 please share her last two 24 hour urine for creatinine and protein. Her lupus nephritis may have also flared up now after her stopping the steroids. Her serum albumin has fallen to 1.8 and she also looks cachectic today
[07/05/2025, 15:05] Rakesh Biswas: Yesterday's intake output
3000 ml/20 ml
Pulse iv methyl prednisolone today
[08/05/2025, 11:07] Rakesh Biswas: Apparently as per @Akash Deep Kims 2023 passed 120 ml yesterday on Day 2. Day 1 as mentioned earlier was 20 ml.
Received 750 mg of methyl prednisolone iv yesterday
[09/05/2025, 15:40] Rakesh Biswas: @Harika 2024 Kims Medicine PG @Anonymous Pm @Jitendra Kims PG Med 24 @Meta AI @Dr.Abdulsalam Med Ed Leads given that this patient's lupus nephritis has been smoldering since September 2022 when @Sai Charan Kulkarni 2020 KIMS Pg @pajr.in CEO, NHS Endocrinologist met her for the first time and now 2 and half years later with this current lupus nephritis crisis causing azotemia and oliguria, now that we have given crisis management pulse of Methyl prednisolone, we will likely continue oral prednisolone 30 mg once daily but will now have to decide which adjuvant to add to it seeing that we have failed azathioprine and mycofenolate mofetil already. Cyclosporine given her azotemia is not a good option and tacrolimus could be even more expensive than MMF?
Which adjuvant therapy with her maintenance oral Prednisolone would be best in the current circumstances?
[09/05/2025, 15:40] Meta AI: Given the patient's history of lupus nephritis, failure on azathioprine and mycophenolate mofetil (MMF), and current azotemia, the choice of adjuvant therapy with oral prednisolone requires careful consideration.
1. *Cyclophosphamide*: Could be considered given its efficacy in treating lupus nephritis, especially in patients who have failed other therapies. However, its use needs careful weighing of benefits versus risks, particularly given potential side effects.
2. *Rituximab*: Some evidence supports its use in refractory lupus nephritis, though it's often considered after failure of other immunosuppressants. Its role in maintenance therapy might be explored.
3. *Belimumab*: This could be an option, especially considering its efficacy in treating systemic lupus erythematosus and potential benefits in renal manifestations. Its use might be limited by cost and accessibility.
Given the patient's renal impairment and the previous failures, it's crucial to discuss the potential benefits and risks of each option with a specialist, considering both efficacy and the side-effect profile. Consult current guidelines and possibly get a second opinion from a nephrologist or rheumatologist experienced in managing lupus nephritis.
[09/05/2025, 16:00] Dr.Abdulsalam Med Ed Leads: In managing this patient's lupus nephritis with a history of treatment failures, particularly involving azathioprine and mycophenolate mofetil (MMF), the selection of adjuvant therapy alongside oral prednisolone necessitates a nuanced approach. Let's explore the three potential options in detail:
### 1. Cyclophosphamide
- **Efficacy**: Cyclophosphamide is well-documented for its effectiveness in treating severe lupus nephritis, particularly in cases resistant to other therapies. It can rapidly reduce proteinuria and improve renal function.
- **Risks**: The side effects include myelosuppression, infection risk, hemorrhagic cystitis, and potential long-term malignancy risks. Given the patient's renal impairment, the dosing and monitoring would need to be carefully managed.
- **Recommendation**: It is a viable option, especially if the risks are deemed acceptable after consultation with the patient about the potential side effects and monitoring requirements.
### 2. Rituximab
- **Efficacy**: Rituximab has been shown to be effective in refractory lupus nephritis and is often used in cases where traditional immunosuppressants have failed. Its mechanism targets B cells, which are implicated in lupus pathogenesis.
- **Risks**: Side effects can include infusion reactions, infections, and potential impact on immunoglobulin levels, leading to increased infection risk. The effects on renal function need further evaluation, particularly in patients with azotemia.
- **Recommendation**: This could be a good option if the patient can tolerate the infusion and if costs and insurance coverage allow. It might be particularly attractive if there's resistance to cyclophosphamide or concerns about its long-term side effects.
### 3. Belimumab
- **Efficacy**: Belimumab has shown benefits in treating systemic lupus erythematosus (SLE) and appears to have some efficacy for renal manifestations. It is generally considered when other agents have failed, but it could be beneficial as part of a treatment regimen.
- **Risks**: Safety profile appears favorable, but it still poses a risk of infections and infusion reactions. Its efficacy may be lower than that of cyclophosphamide or rituximab specifically for severe lupus nephritis.
- **Recommendation**: While it could be considered, especially if the patient's disease is more generalized and not limited to renal involvement, its efficacy specifically for managing lupus nephritis might not be as robust as the other two options.
### Conclusion
In approaching this patient's treatment:
- Engage the patient in a detailed discussion about the potential treatment options, their benefits, risks, and the importance of adherence and follow-up.
- Consultation with a specialist is essential to tailor the treatment plan based on the patient's renal function, the severity of the lupus nephritis, and previous treatment responses.
- Regular monitoring and adjustments based on renal function and side effect profiles will be crucial for managing therapy effectively.
Involving an experienced rheumatologist or nephrologist would be advisable to navigate these complex decisions and possibly look for clinical trials that might provide access to newer therapies or protocols.ChatGPT
[10/05/2025, 15:11] Rakesh Biswas: Today's update: urine output recovering
[10/05/2025, 15:11] Rakesh Biswas: I/O 2250/650
[12/05/2025, 11:53] Rakesh Biswas: Today's update from @Parimala Gurram Kims 2024 PG Med :
Yesterday's urine output 1.5 liters
Final diagnosis at discharge today:
AKI with oliguria after acute vomiting and diarrhoea
Treated as Lupus flare with iv methyl prednisolone for three days
Biopsy staged class 2 lupus nephritis
Recent 24 hour protein in April 2025 shows 2.7 g of proteinuria and serum albumin is 1.8 suggestions of ongoing nephrotic syndrome due to lupus nephritis
Past history of azathioprine induced dose dependent pancreatitis
MMF intolerance
Treatment plan:
Continue Tablet prednisolone 30 mg once daily and slow taper after few weeks to 10 mg and restart MMF in very low dose to induce tolerance
[12/05/2025, 13:11] Rakesh Biswas: @Parimala Gurram Kims 2024 PG Med I don't see that the diagnosis portion in the patient's discharge has been edited as per my above suggestions 👇
Age/Gender : 22 Years/Female
Address :
Discharge Type: Lama
Admission Date: 06/05/2025 01:56 AM
Name of Treating Faculty DR MANOJ (ASST PROF) DR RAMBABU (SR)
DR PRACHETHAN (PGY3) DR HARIKA (PGY3)
DR AKASH (PGY2) DR PARIMALA (PGY1) DR HARIKA (PGY1)
Diagnosis
ADDISONIAN CRISIS /MMF INDUCED ENTERITIS (RESOLVED)
AZATHIOPRINE INDUCED PANCREATITIS (RESOLVED) ? SLE WITH MESENTRIC VASCULITIS LUPUS NEPHRITIS STAGE 2
DILUTION HYPONATREMIA
PAST HISTORY OF RIGHT SIDED HYDROPNEUMOTHORAX S/P ICD PLACEMENT DONE REMOVED
K/C/O HYPERTENSION
Case History and Clinical Findings
COMPLAINTS AND DURATION
LOOSE STOOLS 5 TO 6 EPISODES SINCE TODAY MORNING (6/5/25) VOMITINGS 3 EPISODES SINCE TODAY MORNING
HISTORY OF PRESENTING ILLNESS :
PATIENT WAS APPARENTLY ASYMPTOMATIC SINCE TODAY MORNING THEN SHE DEVELOPED LOOSE STOOLS ,4 TO 5 EPISODES MUCOID IN CONSISTENCY , NON BLOOD STAINED ,NON FOUL SMELLING ,MINIMAL IN QUANTITY ASSOCIATED WITH TENESMUS
HISTORY OF VOMITING SINCE TODAY MORNING 3 EPISODES, WATER AS CONTENT ,NON BILIOUS , NON BLOOD STAINED , NON PROJECTILE
SHE ALSO COMPLAINS OF EPIGASTRIC PAIN WHICH IS INSIDIOUS IN ONSET , SQUEEZING TYPE , NON RADIDATING ,NO AGGRAVATING AND RELIEVING FACTORS .
H/O CONSUMPTION OF CHICKEN YESTERDAY NIGHT ,SINCE THEN SYMPTOMS DEVELOPED.
PAST ILLNESS:
KNOWN CASE OF SLE ? MESENTRIC VASCULITIS
KNOWN CASE OF LUPUS NEPHRITIS ON METHYL PREDNISOLONE 20MG AND MYCOPHENOLATE MOFETIL 500MG
HISTORY OF HYPERTENSION SINCE 2 MONTHS ON TAB.AMLODIPINE 10MG OD 9 IRREGULAR MEDICATION )
HISTORY OF PANCREATITIS
HISTORY ICD PLACEMENT 1 YEAR BACK HISTORY DRUG INDUCED GASTRITIS
NOT A KNOWN CASE OF DM, THYROID ,ASTHMA , CVA , CAD ,EPILEPSY PERSONAL HISTORY:
SINGLE, APPETITTE LOST , CONSUMES MIXED DIET , NORMAL MICTURITION. NO KNOWN AALERGIES ,ADDICTIONS : REGULAR ALCOHOL INTAKE
FAMILY HISTORY:
NOT SIGNIFICANT GENERAL EXAMINATION:
NO PALLOR, ICTERUS, CYANOSIS, CLUBBING, LYMPHADENOPATHY, MALNUTRITION VITALS
TEMP: 97.2 FPR: 104 BPM BP: 140/90MMHGRR: 16 CPM SPO2: 99% AT ROOM AIR
SYSTEMIC EXAMINATION:
CVS- S1 S2 HEARD, NO MURMURS
RS- NORMAL VESICULAR BREATH SOUNDS PRESENT, BILATERAL AIR ENTRY PRESENT P/A - SOFT, NON TENDER, NO ORGANOMEGALY
CNS- HIGHER MENTAL FUNCTIONS INTACT, NO FOCAL NEUROLOGICAL DEFICIT TONE - RIGHT LEFT
UL NORMAL NORMAL LL NORMAL NORMAL
POWER- RIGHT LEFT UL 5/5 5/5
LL 5/5 5/5 REFLEXES BICEPS +2 +2
TRICEPS +2 +2
SUPINATOR +2 +2
KNEE +2 +2
ANKLE +2 +2
PLANTAR FLEXOR FLEXOR COURSE IN THE HOSPITAL
LOOSE STOOLS 5 TO 6 EPISODES SINCE DAY 1, VOMITINGS 3 EPISODES SINCE DAY 1, DAY 3 C/O PAIN ABDOMEN, VOMITING, LOOSE STOOLS WAS SUBSIDED, ON DAY 4 SERUM ELECTROLYTES WERE SENT AND DILUTIONAL HYPONATREMIA WAS EVALUATED, ON DAY 5 PEDAL EDEMA DECREASED
PATIENT WAS TREATED SYMTOMATICALLY BY CORTICOSTEROID GIVEN FOR 3 DAYS, PROTON PUMP INHIBITOR GIVEN FOR 7 DAYS, 5-HT3 RECEPTOR BLOCKER (ANTI EMETIC MEDICATION) WAS GIVEN FOR 4 DAYS, IV FLUIDS NS GIVEN FOR 7 DAYS, CALCIUM CHANNEL BLOCKED (ANTI HYPERTENSIVE MEDICATION) GIVEN FOR 7 DAYS, ANGIOTENSIVE RECEPTOR BLOCKER(ANTI HYPERTENSIVE MEDICATION) GIVEN FOR 7 DAYS, ANTI-SPASMODICS (PAIN RELIEVE) GIVEN FOR 7 DAYS, IRON SUPPLIMENTATION GIVEN FOR 1 DAY, PROBIOTICS (FOR LOOSE STOOLS) GIVEN FOR 4 DAYS, DIURETIC GIVEN FOR 3 DAYS. VITALS WERE MONITORED AND ALL NECESSARY INVESTIGATIONS WERE SENT.
PATIENT WAS HEMODYNAMICALLY STABLE DURING THE HOSPITAL STAY AND THE PATIENT IS BEING DICHARGED IN HEMODYNAMICALLY STABLE CONDITION
Investigation
DATE :6-5-25
HBsAg-RAPID 06-05-2025 Negative
Anti HCV Antibodies - RAPID 06-05-2025 Non ReactiveBLOOD UREA 06-05-2025 37 mg/dl SERUM CREATININE 06-05-2025 02:27:AM 1.4 mg/dl
SERUM ELECTROLYTES (Na, K, C l) 06-05-2025SODIUM 143 mmol/LPOTASSIUM 3.7
mmol/LCHLORIDE 105 mmol/L
LIVER FUNCTION TEST (LFT) 06-05-2025 Total Bilurubin 1.10 mg/dl Direct Bilurubin 0.20 mg/dlSGOT(AST) 19 IU/LSGPT(ALT) 12 IU/LALKALINE PHOSPHATASE 135 IU/LTOTAL
PROTEINS 3.7 gm/dl ALBUMIN 1.8 gm/dlA/G RATIO 0.94
SERUM ELECTROLYTES (Na, K, C l) 08-05-2025 SODIUM 132 mmol/LPOTASSIUM 3.8 mmol/L CHLORIDE 101 mmol/L
HAEMOGLOBIN 9.8 gm/dl TOTAL COUNT 8,100 cells/cumm NEUTROPHILS 84 %LYMPHOCYTES 12 % EOSINOPHILS 01 %MONOCYTES 03 % BASOPHILS 00 % PCV 30.8 vol %M C V 82.5 fl M C H 26.3 pg M C H C 31.9 % RDW-CV 16.0 %RDW-SD 48.2 flRBC COUNT 3.73 millions/cumm
PLATELET COUNT 4.5 lakhs/cu.mm SMEARRBC Normocytic normochromicWBC With in normal limits with increasedneutrophilsPLATELETS Adequate in number and distribution HEMOPARASITES No hemoparasites seen IMPRESSION Normocytic normochromic anemiawith neutrophilia
HIV 1/2 Rapid Test Non Reactive
24 HOURS URINEPROTEIN105 mg/day. <150 mg/day24 HOURS URINECREATININE0.5 g/day 1-3 gm /dayRATIO 0.21URINE VOLUME 230 ml
SERUM ELECTROLYTES (Na, K, C l)
SODIUM 132 mmol/LPOTASSIUM 3.8 mmol/L CHLORIDE 101 mmol/LCALCIUM IONIZED 1.15
mmol/L
Treatment Given(Enter only Generic Name)
1. PULSE THERAPY INJ. METHYL PREDNISOLONE 750 MG IV IN 100ML NS OVER 30 MINUTES FOR 3 DAYS
2. INJ. PAN 40MG IV/OD
3. INJ.ZOFER 4MG IV/OD
4. IV FLUIDS NS @ 50ML/HOUR
5. TAB. AMLONG 10MG PO/OD 8AM-X-X
6. TAB.TELMA 40MG PO/OD X-2PM-X
7. TAB.BUSCOPAN PO/SOS
8. TAB.OROFER XT PO/OD X-2PM-X
9. T.SPOROLAC OS PO/TID 1-1-1
10. 2-3 EGG WHITES PER DAY
Advice at Discharge
1. TAB. PREDNISOLONE 30 MG PO/OD 8AM-X-X TO BE CONTINUED
2. TAB. PANTOP 40MG IV/OD 7AM-X-X 30MINS BEFORE BREAKFAST FOR 7 DAYS
3. TAB. AMLONG 10MG PO/OD 8AM-X-X TO BE CONTINUED
4. TAB.TELMA 40MG PO/OD X-2PM-X TO BE CONTINUED
5. 2-3 EGG WHITES PER DAY
Follow Up
REVIEW TO GENERAL MEDICNE OPD AFTER 2 WEEKS
When to Obtain Urgent Care
IN CASE OF ANY EMERGENCY IMMEDIATELY CONTACT YOUR CONSULTANT DOCTOR OR ATTEND EMERGENCY DEPARTMENT.
Preventive Care
AVOID SELF MEDICATION WITHOUT DOCTORS ADVICE,DONOT MISS MEDICATIONS. In case
of Emergency or to speak to your treating FACULTY or For Appointments, Please Contact: For Treatment Enquiries Patient/Attendent Declaration : - The medicines prescribed and the advice regarding preventive aspects of care ,when and how to obtain urgent care have been explained to me in my own language
SIGNATURE OF PATIENT /ATTENDER SIGNATURE OF PG/INTERNEE SIGNATURE OF ADMINISTRATOR SIGNATURE OF FACULTY
Discharge Date Date: 12/05/2025 Ward:AMC
Unit: 1
[12/05/2025, 16:35] Dr.Abdulsalam Med Ed Leads: Here’s a **refined and polished version** of the **Diagnosis** section, incorporating hierarchical structuring, precise terminology, and clearer categorization for clinical accuracy and readability:
---
### **Final Diagnosis**
#### **Active Diagnoses on Discharge:**
1. **Systemic Lupus Erythematosus (SLE) with:**
- **Lupus Nephritis (Class II)** (confirmed histologically/clinical criteria).
- **Suspected Mesenteric Vasculitis** (resolved with corticosteroid therapy).
2. **Drug-Induced Complications (Resolved During Admission):**
- **Mycophenolate Mofetil (MMF)-Induced Enteritis** (resolved after MMF discontinuation).
- **Azathioprine-Induced Pancreatitis** (resolved post-drug withdrawal).
3. **Adrenal Insufficiency:**
- **Addisonian Crisis** (resolved with pulse methylprednisolone).
4. **Hypertension** (poorly controlled, on dual therapy with amlodipine + telmisartan).
#### **Secondary/Contributing Diagnoses:**
1. **Dilutional Hyponatremia** (corrected with fluid management).
2. **Normocytic Normochromic Anemia with Neutrophilia** (likely chronic disease-related).
#### **Past Medical/Surgical History:**
- **Right-Sided Hydropneumothorax** (status post ICD placement and removal, 1 year ago).
- **Drug-Induced Gastritis** (resolved, no active symptoms).
- **Irregular Adherence to Antihypertensives** (requires counseling).
---
### **Key Refinements:**
1. **Hierarchical Organization:**
- Separated **active/resolved**, **primary/secondary**, and **past** diagnoses for clarity.
- Grouped SLE-related manifestations under one heading.
2. **Precision in Terminology:**
- Specified **"Class II"** for lupus nephritis (replacing "Stage 2").
- Added **etiology** for drug-induced conditions (e.g., MMF, azathioprine).
3. **Resolution Status:**
- Clearly labeled resolved conditions (e.g., pancreatitis, enteritis) to avoid ambiguity.
4. **Hypertension Context:**
- Highlighted **"poorly controlled"** status and dual therapy to guide follow-up.
5. **Anemia Classification:**
- Linked neutrophilia/normocytic anemia to chronic inflammation (SLE) rather than isolated iron deficiency.
---
### **Additional Recommendations for Discharge Summary:**
- **Medication Reconciliation:**
- Ensure **prednisolone** is continued for SLE/adrenal insufficiency.
- Avoid rechallenging **azathioprine/MMF** given prior adverse reactions.
- **Follow-Up Priorities:**
- Monitor **SLE activity**: Repeat 24-hour urine protein, complement levels, and renal function.
- **Hypertension control**: Schedule BP checks weekly; emphasize adherence.
- **Adrenal function testing**: AM cortisol/ACTH stimulation test if recurrent crises.
- **Patient Education:**
- Avoid NSAIDs/self-medication (risk of gastritis/SLE flare).
- Alcohol cessation (listed in history as "regular alcohol intake").
---
Let me know if you need adjustments to align with institutional templates or specific clinical guidelines!
[16/05/2025, 21:46] Pushed Communicator 1N22: @Rakesh Biswas we didn’t advise any diuretic at discharge as her pedal edema resolved and output was good without diuretic
Shall i ask them to come tomorrow to get sr albumin and urine protein done and add tab lasix for now
[16/05/2025, 21:47] Rakesh Biswas: Can ask her to start lasix 40 mg from tomorrow morning
No comments:
Post a Comment